FIND OUT IF HFX™ IS RIGHT FOR YOU

If your painful diabetes-related neuropathy isn’t responding to
treatment, talk to us about HFX™

Painful Diabetic Neuropathy (PDN): A Chronic, Debilitating Pain with Limited Treatment Options

  • 34 million people have diabetes in the U.S.(1) and roughly half of all adults with diabetes will suffer from diabetic neuropathy in their lifetime(2)
  • ~2.3MM patients suffer from PDN with no relief from current treatments(3)
  • Diabetic neuropathy is nerve damage caused by high blood sugars
  • Nerve damage can cause pain and numbness that can make you more vulnerable to falls, burns, infections, ulcers, and longer-term complications.
  • Painful diabetic neuropathy can significantly interfere with your quality of life, sleep, and functionality.

Current Treatments Leave Room for Improvement

  • Treatment options include over-the-counter medications, prescription medications, physical therapy or injections, however for many patients these options are inadequate for long-term relief.
  • Opioids, a commonly used tool in the management of diabetes related neuropathy, also present addiction potential, long-term dependence and show little evidence of improved function.
INTRODUCING HFX™ FOR PDN

A Safe and Effective Spinal Cord Stimulation System for Painful Diabetic Neuropathy, without the side effects of prescription medications.

  • A new treatment is available to help you manage shooting, burning, pins and needles pain associated with diabetic neuropathy
  • Significantly reduces pain and improves sleep(4)
  • Reduces painful sensations like burning, tingling, and numbness(4)
  • Patients can evaluate HFX in a temporary trial before having the device implanted. The implant procedure requires a minimally invasive outpatient procedure.
  • 92% of patients were satisfied with their treatment(4)

Request An Appointment

Please feel free to contact our friendly reception staff with any general or medical inquiry

DOUBLE BOARD-CERTIFIED

Dr. David J. Arcella

Dr. David J. Arcella is a Harvard trained Interventional Pain Management Specialist. He has contributed to research in opioid alternative medications and medication-free pain management options, as well as surgical anesthesia techniques to minimize the incidence of chronic pain. Dr. Arcella believes in creating a collaborative care plan with his patients and customizing treatments to each patient’s individual goals.

Testimonials

ACCEPTED

Insurances

  • Aetna
  • All BCBS plans

  • Cigna

  • Humana

  • Mail Handlers

  • Medicare

  • MedicareMedicare HMO’s

  • Medicost
  • Out of Network
    (In network with Molina Healthcare or Wellcare)
  • Planned Administrators

  • Thomas Cooper

  • Tricare

  • United Healthcare

  • Work Comp

Insurances We Accept DeNovo Pain Management
ACCEPTED

Insurances

  • Aetna
  • All BCBS plans

  • Cigna

  • Humana

  • Mail Handlers

  • Medicare

  • MedicareMedicare HMO’s

  • Medicost
  • Out of Network
    (In network with Molina Healthcare or Wellcare)
  • Planned Administrators

  • Thomas Cooper

  • Tricare

  • United Healthcare

  • Work Comp

References: 

  1. CDC 2020 National Diabetes Statistics Report.
  2. Hicks CW, Selvin E. Curr Diab Rep. 2019;19(10):86
  3. CDC National Diabetes Statistics Report 2020; Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002;18(6):350-354; Trinity Partners Market Research 2017
  4. Petersen, E, et. al. Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy A Randomized Clinical Trial. JAMA Neurology, April 2021.

References: 

  1. CDC 2020 National Diabetes Statistics Report.
  2. Hicks CW, Selvin E. Curr Diab Rep. 2019;19(10):86
  3. CDC National Diabetes Statistics Report 2020; Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002;18(6):350-354; Trinity Partners Market Research 2017
  4. Petersen, E, et. al. Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy A Randomized Clinical Trial. JAMA Neurology, April 2021.